litigation

News

Novartis knocked back again in bid to block Gilenya generics...

Novartis is running out of options in its bid to defend oral muscular sclerosis therapy Gilenya from early generic competition in the US.

News

Natural killer cells are a type of lymphocytes which destroy cancer cells and other altered cells releasing cytotoxic granules.

Merck to pay BMS $625m in cancer patent case

Case settles patent case related to rival immunotherapies.

News

Insys execs face jail for illegal US prescription conspiracy

The founder of Insys Therapeutics, John Kapoor, and four colleagues face jail after a US court convicted them of a racketeering conspiracy where doctors were illegally induced to prescribe

News

Report claims Bayer is already hunting for a new CEO

Bayer chief executive Werner Baumann has been under fire from investors since he spearheaded the acquisition of agrochemical company Monsanto for $63 billion, exposing the group to multibil

News

Illumina defeats FTC bid to dismantle Grail takeover

A judge in the US has ruled in favour of Illumina in a dispute with the Federal Trade Commission (FTC) over its multibillion-dollar takeover of cancer diagnosis specialist Grail, which had

News

AZ blocks former exec from taking up role at GSK – for now

AstraZeneca has succeeded in a last-gasp effort to stop its former head of investor relations joining rival UK pharma group GSK, after winning an injunction in the High Court in London.

Novartis knocked back again in bid to block Gilenya generics...

Merck to pay BMS $625m in cancer patent case

Insys execs face jail for illegal US prescription conspiracy

Report claims Bayer is already hunting for a new CEO

Illumina defeats FTC bid to dismantle Grail takeover

AZ blocks former exec from taking up role at GSK – for now

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

litigation

Editor's Picks